The goal of the Academic Drug Discovery Consortium (ADDC) is to build a collaborative network among the growing number of university-led drug discovery centers and programs. With this interactive website, we aim to allow scientists to exchange technical expertise on drug discovery and development strategies as well as form partnerships with each other, biopharma companies, and drug discovery-focused contract service organizations and consultants. The website will also serve as a repository for drug discovery events, educational material, job postings, and partnership opportunities. It is with the active participation of each ADDC member that this website will become a valuable tool for every scientist working in the drug discovery arena. In addition, involvement of our members will enable the ADDC to effectively advocate to the NIH and other funding agencies to increase the awareness of the growing number of academic drug discovery scientists and their success as well as their needs.


CO-ADD (Community for Open Antimicrobial Drug Discovery)

CO-ADD is a not-for-profit initiative led by academics.

Our goal is to screen compounds for antimicrobial activity for academic research groups from anywhere in the world for free. We make no claim to IP or results.

We aim to help resea...

View all


Sanford-Burnham Partners with Johnson and Johnson to Identify New Treatments for Neurological Disorders

Sanford-Burnham Medical Institute and Janssen a unit of Johnson and Johnson have entered into research and development partnership to identify novel targets and develop drugs to treat Alzheimer's disease and psychiatric disorders. This multi year ...

View all


    No Job Posts


Roche Phizer Sigma-Aldrich HL Xenotech Xenotech Eurofins Roche Phizer Sigma-Aldrich HL Xenotech Xenotech Eurofins
View All